{"nct_id":"NCT02737475","title":"An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread","status":"COMPLETED","status_verified_date":"2021-12","start_date":"2016-06-17","start_date_type":"ACTUAL","primary_completion_date":"2020-11-02","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-02","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}